EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novavax Boosts Revenue Outlook Amid Vaccine Demand Challenges, ETPharma
Novavax Q2 Earnings Call Highlights
Novavax (NASDAQ:NVAX) Posts Earnings Results, Beats Estimates By $0.06 EPS
Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...
Novavax Slips To Loss In Q2 On Reduced Revenue, Cuts FY26 Guidance
Novavax (NASDAQ:NVAX) Exceeds Q2 CY2026 Expectations
Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights | Morningstar
Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand
NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals
Edgestream Partners L.P. Makes New $4.23 Million Investment in Novavax, Inc. $NVAX - Daily Political
Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026
Novavax (NVAX) Expected to Post Earnings on Wednesday
Novavax (NVAX) Stock May Be Fully Priced Given Its Sales Outlook
Novavax, Inc. (NASDAQ:NVAX) Receives Average Rating of "Hold" from Brokerages
Novavax (NVAX) Could Be 32% Undervalued As Russell Index Exit Reshapes The View
Head to Head Contrast: Basilea Pharmaceutica (OTCMKTS:BPMUF) and Novavax (NASDAQ:NVAX) - Stock Observer
Novavax Target of Unusually Large Options Trading (NASDAQ:NVAX)
Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?
Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters
Zacks Research Predicts Novavax's Q1 Earnings (NASDAQ:NVAX)
